121 related articles for article (PubMed ID: 36588408)
1. Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 years.
Forni GL; Gianesin B; Musallam KM; Longo F; Rosso R; Lisi R; Gamberini MR; Pinto VM; Graziadei G; Vitucci A; Bonetti F; Musto P; Piga A; Cappellini MD; Borgna-Pignatti C;
Am J Hematol; 2023 Mar; 98(3):381-387. PubMed ID: 36588408
[TBL] [Abstract][Full Text] [Related]
2. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
[TBL] [Abstract][Full Text] [Related]
3. Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.
Chern JP; Su S; Lin KH; Chang SH; Lu MY; Jou ST; Lin DT; Ho WL; Lin KS
Pediatr Blood Cancer; 2007 May; 48(5):550-4. PubMed ID: 16972241
[TBL] [Abstract][Full Text] [Related]
4. Survival and disease complications in thalassemia major.
Borgna-Pignatti C; Rugolotto S; De Stefano P; Piga A; Di Gregorio F; Gamberini MR; Sabato V; Melevendi C; Cappellini MD; Verlato G
Ann N Y Acad Sci; 1998 Jun; 850():227-31. PubMed ID: 9668544
[TBL] [Abstract][Full Text] [Related]
5. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A
Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited.
Derchi G; Dessì C; Bina P; Cappellini MD; Piga A; Perrotta S; Tartaglione I; Giuditta M; Longo F; Origa R; Quarta A; Pinto V; Forni GL;
Intern Emerg Med; 2019 Apr; 14(3):365-370. PubMed ID: 29948832
[TBL] [Abstract][Full Text] [Related]
7. HLA-matched sibling bone marrow transplantation for β-thalassemia major.
Sabloff M; Chandy M; Wang Z; Logan BR; Ghavamzadeh A; Li CK; Irfan SM; Bredeson CN; Cowan MJ; Gale RP; Hale GA; Horan J; Hongeng S; Eapen M; Walters MC
Blood; 2011 Feb; 117(5):1745-50. PubMed ID: 21119108
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the patients with thalassemia major for long-term endocrinological complications after bone marrow transplantation.
Aldemir-Kocabaş B; Tezcan-Karasu G; Bircan I; Bircan O; Aktaş-Samur A; Yeşilipek MA
Pediatr Hematol Oncol; 2014 Oct; 31(7):616-23. PubMed ID: 24852067
[TBL] [Abstract][Full Text] [Related]
9. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
Maggio A; Vitrano A; Capra M; Cuccia L; Gagliardotto F; Filosa A; Magnano C; Rizzo M; Caruso V; Gerardi C; Argento C; Campisi S; Cantella F; Commendatore F; D'Ascola DG; Fidone C; Ciancio A; Galati MC; Giuffrida G; Cingari R; Giugno G; Lombardo T; Prossomariti L; Malizia R; Meo A; Roccamo G; Romeo MA; Violi P; Cianciulli P; Rigano P
Blood Cells Mol Dis; 2009; 42(3):247-51. PubMed ID: 19233692
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C
Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation for thalassemia. The USA experience.
Walters MC; Sullivan KM; O'Reilly RJ; Boulad F; Brockstein J; Blume K; Amylon M; Johnson FL; Klemperer M; Graham-Pole J
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):11-7. PubMed ID: 8311166
[TBL] [Abstract][Full Text] [Related]
12. Survival and complications in thalassemia.
Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in bone marrow transplantation for beta thalassemia major: experiences from Iran.
Ghavamzadeh A; Nasseri P; Eshraghian MR; Jahani M; Baybordi I; Nateghi J; Khodabandeh A; Sadjadi AR; Mohyeddin M; Khademi Y
Bone Marrow Transplant; 1998 Dec; 22(12):1167-9. PubMed ID: 9894719
[TBL] [Abstract][Full Text] [Related]
14. Results of therapy for beta-thalassemia major.
Lin KH; Lin KS
J Formos Med Assoc; 1992 Feb; 91(2):126-30. PubMed ID: 1364206
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
17. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group.
Yesilipek MA; Ertem M; Cetin M; Öniz H; Kansoy S; Tanyeli A; Anak S; Kurekci E; Hazar V
Pediatr Transplant; 2012 Dec; 16(8):846-51. PubMed ID: 22931438
[TBL] [Abstract][Full Text] [Related]
18. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
[TBL] [Abstract][Full Text] [Related]
19. Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.
Bhatia S; Dai C; Landier W; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Bosworth A; Te HS; Francisco L; Bhatia R; Salzman D; Goldman FD; Forman SJ; Weisdorf DJ; Wong FL; Arora M; Armenian SH
JAMA Oncol; 2021 Nov; 7(11):1626-1634. PubMed ID: 34499078
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Blood Transfusion Plus Chelation Therapy and Bone Marrow Transplantation in Patients with β-Thalassemia: Application of SF-36, EQ-5D, and Visual Analogue Scale Measures.
Javanbakht M; Keshtkaran A; Shabaninejad H; Karami H; Zakerinia M; Delavari S
Int J Health Policy Manag; 2015 Jun; 4(11):733-40. PubMed ID: 26673333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
